Approval · Notice of Compliance 4232 · 1996
BECLOVENT: Notice of Compliance 4232
Issued March 20, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4232
- Date
- March 20, 1996
- Company
- Glaxo Wellcome Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Corticosteroid for the treatment of bronchial asthma
Products in this notice
Medicinal ingredients
- BECLOMETHASONE DIPROPIONATE 50 MCG per ACT
- BECLOMETHASONE DIPROPIONATE 100 MCG per CAP
- BECLOMETHASONE DIPROPIONATE 200 MCG per CAP